Omega Healthcare Investors, Inc. $OHI Stock Position Decreased by Adelante Capital Management LLC

Key Points

• Adelante Capital Management LLC reduced its stake in Omega Healthcare Investors, Inc. by 23.1% during Q1, now holding 337,195 shares valued at approximately $12.84 million.
• Insider activity shows that Director Lisa Egbuonu-Davis sold 2,500 shares at an average price of $40.16, decreasing her position by 11.82%.
• Omega Healthcare Investors reported $0.77 EPS for the last quarter, surpassing expectations, and has a dividend yield of 6.2% with a recent quarterly payout of $0.67.

Adelante Capital Management LLC decreased its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 23.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 337,195 shares of the real estate investment trust's stock after selling 101,431 shares during the quarter. Omega Healthcare Investors comprises about 0.9% of Adelante Capital Management LLC's holdings, making the stock its 27th largest position. Adelante Capital Management LLC owned 0.12% of Omega Healthcare Investors worth $12,840,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Optimum Investment Advisors boosted its holdings in Omega Healthcare Investors by 8.9% in the 1st quarter. Optimum Investment Advisors now owns 3,666 shares of the real estate investment trust's stock worth $140,000 after acquiring an additional 300 shares during the period. CreativeOne Wealth LLC boosted its stake in shares of Omega Healthcare Investors by 3.4% during the 1st quarter. CreativeOne Wealth LLC now owns 9,487 shares of the real estate investment trust's stock valued at $361,000 after buying an additional 310 shares during the last quarter. Values First Advisors Inc. boosted its stake in shares of Omega Healthcare Investors by 1.6% during the 1st quarter. Values First Advisors Inc. now owns 19,692 shares of the real estate investment trust's stock valued at $750,000 after buying an additional 314 shares during the last quarter. QRG Capital Management Inc. boosted its stake in shares of Omega Healthcare Investors by 0.5% during the 1st quarter. QRG Capital Management Inc. now owns 69,499 shares of the real estate investment trust's stock valued at $2,647,000 after buying an additional 341 shares during the last quarter. Finally, Baird Financial Group Inc. boosted its stake in shares of Omega Healthcare Investors by 0.8% during the 4th quarter. Baird Financial Group Inc. now owns 50,492 shares of the real estate investment trust's stock valued at $1,911,000 after buying an additional 380 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company's stock.

Insider Transactions at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares of the company's stock, valued at approximately $749,144.64. This represents a 11.82% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.50% of the company's stock.

Omega Healthcare Investors Trading Up 0.3%

Shares of NYSE:OHI traded up $0.14 during midday trading on Friday, reaching $42.64. The company had a trading volume of 406,789 shares, compared to its average volume of 2,342,582. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. Omega Healthcare Investors, Inc. has a 1-year low of $35.04 and a 1-year high of $44.42. The firm has a market cap of $12.58 billion, a price-to-earnings ratio of 26.32, a price-to-earnings-growth ratio of 2.24 and a beta of 0.71. The company has a fifty day simple moving average of $40.14 and a two-hundred day simple moving average of $38.20.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. The business had revenue of $235.60 million during the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.Omega Healthcare Investors's revenue for the quarter was up 11.8% on a year-over-year basis. During the same quarter last year, the company posted $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were paid a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.3%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio is currently 165.43%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on OHI shares. Wells Fargo & Company upped their price target on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a research report on Wednesday, August 27th. Royal Bank Of Canada raised their target price on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research note on Thursday, August 7th. Truist Financial raised their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research note on Wednesday, September 3rd. Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Finally, Scotiabank raised their target price on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a research note on Thursday, August 28th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, Omega Healthcare Investors has a consensus rating of "Moderate Buy" and an average price target of $43.75.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.